Navigation Links
Study shows universal surveillance for MRSA significantly decreased HAIs at PCMH
Date:7/13/2010

Greenville, NC (July 13, 2010) Pitt County Memorial Hospital (PCMH) today announced results of a study demonstrating that universal surveillance for methicillin-resistant Staphylococcus aureus (MRSA) decreased health care-associated infections (HAIs) related to devices. Infection rates decreased 68 percent for ventilator-associated pneumonias (VAP); 51 percent for central line-associated bacteremias (CLA-BSI); and 49 percent for catheter-associated urinary tract infections (CAUTI).

The study was led by Keith Ramsey, M.D., medical director for infection control at PCMH, and professor of medicine at The Brody School of Medicine at East Carolina University. Universal surveillance, also known as all-admissions surveillance, introduces the testing of all patients upon admission, not just high-risk patients, and has been shown to be far more effective than targeted active surveillance when monitoring for MRSA infections. If patients test positive for MRSA, they are put on contact precautions that include isolation, hand hygiene, room signage, patient-dedicated equipment, personal gowns and gloves, and they are decolonized with mupirocin/chlorhexidine bath.

"At PCMH we have made it our mission to take pre-emptive action to reduce the risk of patients transmitting or acquiring an infection while under our care," Ramsey said. "This particular study demonstrates that universal surveillance plus eradication help to reduce HAIs related to devices, which continues to be a major challenge for hospitals and health care facilities in the United States."

The study was presented today by Kathy Cochran, manager of infection control at PCMH, during a poster session (Poster #: 8-056) at the Association for Professionals in Infection Control and Epidemiology (APIC) 2010 annual conference in New Orleans. The BD GeneOhm MRSA assay, an in vitro molecular diagnostic test that provides definitive results within two hours of laboratory time, was used in the study.

During the surveillance period, rates for MRSA-associated HAIs decreased for each device as follows:

  • VAPs per 1,000 vent days decreased 68 percent from 1.065-to-0.296 (p < 0.006) in the intervention year, and to 0.183 (p < 0.002) in the maintenance year.
  • CLA-BSIs per 1,000 line days decreased 51 percent from 0.244-to-0.124 (p < 0.292) in the intervention year, and to 0.111 in the maintenance year (p < 0.196).
  • CAUTI rates per 1,000 foley days decreased 49 percent from 0.207-to-0.101 (p< 0.254) in the intervention year, and to 0.099 (p < 0.266) during the maintenance year.

In addition to the poster presentation, Ramsey will present Universal MRSA Screening: Selecting the Best Practice for the Best Price on Wednesday, July 14, 2010 at 4 p.m. in Conference Auditorium 3. In addition, Ramsey will discuss necessary steps for implementing universal admission screening for MRSA.

According to the Centers for Disease Control and Prevention (CDC) in American hospitals alone, HAIs account for an estimated 1.7 million infections and 99,000 associated deaths each year. Of these infections:

  • 32 percent of all HAIs are urinary tract infections
  • 22 percent are surgical site infections
  • 15 percent are pneumonia (lung infections)
  • 14 percent are bloodstream infections.

MRSA bacteria can cause a potentially fatal infection that does not respond to commonly used antibiotics and is a significant cause of HAIs. The CDC estimates that approximately 126,000 people are hospitalized each year with MRSA infections, and about 19,000 die, with an estimated annual cost of $3.2 billion to $4.2 billion to U.S. hospitals.


'/>"/>

Contact: Kathy Vigneault
kathleen.vigneault@mslworldwide.com
617-369-8786
Manning Selvage & Lee
Source:Eurekalert

Related medicine news :

1. Study finds lifelong doubling in death risk for men who are obese at age 20 years
2. Arsenic shows promise as cancer treatment, Stanford study finds
3. Study makes exciting progress in elucidating the mechanisms of bortezomib in lymphoma
4. Mayo Clinic study finds apathy and depression predict progression from mild cognitive impairment
5. New study suggests tart cherry juice can be a natural solution for insomnia
6. Study implicates new epigenetic player in mental retardation and facial birth defects
7. LSUHSC study finds early predictors of metabolic syndrome in healthy 7-9 year-olds
8. New UC Davis study finds early Alzheimers identification method
9. Rat Study Sheds Light on Cocaine Addiction
10. Study: Medicare policy may account for growing length of hospice stays in nursing homes
11. Study Suggests Link Between HPV, Skin Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Pass, OR (PRWEB) , ... January 23, 2017 , ... ... took to the air to educate listeners about the benefits of making new water ... the U.S.,” Kleyne said, “it’s appropriate that we expect water infrastructure to become a ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... earned organic certification under the USDA National Organic Program (NOP) for its Portland ... we have established organic production and handling systems to complement our current rigorous ...
(Date:1/23/2017)... ... ... at the Mill”: a story of love and redemption, hope and uncertainty as a ... , “The Inn at the Mill” is the creation of published author, Lois Kulp, ... now living in Berks County on Crow Hill. The inn, the mill and ...
(Date:1/23/2017)... ... , ... Valentine’s Day is a time when many people celebrate romance and love by giving ... looking for the ideal present, Atlanta-based Perimeter Plastic Surgery is offering a Valentine’s ... spend $200 and get $50 free. , “A lot of people just buy the ...
(Date:1/21/2017)... ... January 21, 2017 , ... Caronlab Australia, an Australian company ... ECRM Trade Show in Hilton Head, SC, where it benefited from outstanding meetings with ... of its beauty and wellness products. At this trade show, the company had the ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... -- Ahead of today,s trading session, Stock-Callers.com draws investors, ... at the close: Kite Pharma Inc. (NASDAQ: KITE ), ... and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ). According to ... Friday, January 20 th , 2017, down on the day by ... stocks now at: ...
(Date:1/23/2017)... 2017 Longer life expectancy and rising healthcare expenditure ... for medical device technologies. BCC Research reveals in its new ... region, should see strong growth due to rising government healthcare ... Continue Reading ... ...
(Date:1/23/2017)... -- ResMed (NYSE: RMD ), BMC (Peking, ... Winter Haven, Florida ) gaben heute bekannt, dass ... globalen Rechtsstreitigkeiten zwischen den Parteien geeinigt haben. BMC und ... im Tausch gegen Lizenzgebühren an ResMed gestattet, und ResMed ... in Florida anhängige Rechtsverfahren zwischen ...
Breaking Medicine Technology: